ArticleTranslational cancer research2020
Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment.
Shibani Mukherjee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it